Anaplastic Thyroid Carcinoma with Gastric Metastasis

por CHAVEZ, A.A.L., IYER, P., CAZACU, I.M., CABANILLAS, M.E., RASHID, A., BHUTANI, M.S.
Publicado 2018

Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study

por Subbiah, V., Kreitman, R. J., Wainberg, Z. A., Cho, J. Y., Schellens, J. H. M., Soria, J. C., Wen, P. Y., Zielinski, C. C., Cabanillas, M. E., Boran, A., Ilankumaran, P., Burgess, P., Romero Salas, T., Keam, B.
Publicado 2022

Selective RET kinase inhibition for patients with RET-altered cancers

por Subbiah, V, Velcheti, V, Tuch, B B, Ebata, K, Busaidy, N L, Cabanillas, M E, Wirth, L J, Stock, S, Smith, S, Lauriault, V, Corsi-Travali, S, Henry, D, Burkard, M, Hamor, R, Bouhana, K, Winski, S, Wallace, R D, Hartley, D, Rhodes, S, Reddy, M, Brandhuber, B J, Andrews, S, Rothenberg, S M, Drilon, A
Publicado 2018